Objectives: Carotid artery stenting (CAS) remains an effective alternative to carotid endarterectomy (CEA) for stroke prevention; however, the long-term durability of CAS remains poorly defined. We performed a 10-year comparative analysis of CEA and CAS to help better evaluate the durability of these procedures.
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The Natural History of Carotid Occlusion Objectives: Carotid stenosis is an important risk factor for ischemic stroke. The management of asymptomatic carotid stenosis is controversial, with various approaches recommending revascularization with carotid endarterectomy or carotid stent for stenosis of 60% to 99%, revascularization for stenosis >75%, revascularization for high-risk patients only, or intensive modern medical treatment. Few studies have noted the incidence of neurologic events in medically treated patients who progress to carotid occlusion. The aim of this study was to describe the natural history of patients with carotid stenosis that progressed to carotid occlusion and to determine the incidence of a neurologic event in this population.
Methods: Loyola University Medical Center Vascular Lab data from 2011 to 2016 were used to identify patients with internal carotid artery occlusion, and their electronic medical records were reviewed for prior carotid ultrasound imaging, computed tomography angiography, magnetic resonance angiogram, or angiogram that did not show evidence of occlusion. The retrospective natural history of this study population was then recorded, including demographics, comorbidities, and medications. The incidence of a neurologic event, defined as the occurrence of transient ischemic attack or cerebrovascular accident was calculated. Comparisons were then drawn between the carotid occlusion group that suffered a neurologic event and the group that did not during the course of carotid disease progression.
Results: The initial search yielded 379 patients with occlusive carotid disease. Of these, 16 patients (4%) demonstrated progression from asymptomatic carotid stenosis to occlusion. Among these 16 patients, the mean age was 71.8 years, 87.5% were men, 87.5% had hypertension, 50% had diabetes mellitus, 6.3% had a history of atrial fibrillation, 68.8% had a smoking history, 6.3% had a history of deep vein thrombosis or pulmonary embolism, 75% were on aspirin therapy, 25% were on clopidogrel, and 81.3% were on a statin. Seven patients (44%) suffered a transient ischemic attack or cerebrovascular accident. The degree of carotid stenosis present prior to the neurologic event ranged from 1% to 49% (2 patients), 50% to 79% (4 patients), and 80% to 99% (1 patient). There were no significant differences in risk factors between the group that suffered a neurologic event and the group that did not.
Conclusions: Progression to carotid occlusion is uncommon, though the incidence of a neurologic event in patients who do progress may be higher than previously thought. Further studies are needed to determine whether stroke prevention in this population is of significant benefit to warrant surgical intervention.
Author Disclosures: B. Aulivola: Nothing to disclose; P. Crisostomo: Nothing to disclose; P. Halandras: Nothing to disclose; L. T. Qu: Nothing to disclose. Objectives: Thoracic outlet syndrome (TOS) is a complex disease process with continued controversy regarding treatment and surgical approach. Understanding causes of treatment failure improves preoperative risk counseling and development of postoperative treatment pathways. We aimed to classify causes for recurrent symptoms in all patients undergoing first rib resection and anterior scalenectomy for TOS.
Methods: At the onset of opening a specialized TOS clinic, a prospective database of all patients evaluated was developed. Patients presenting to the clinic with recurrent symptoms after prior first rib resection and anterior scalenectomy were extracted for review from the database. The type of TOS, patient demographics, prior surgical treatment, length of recurrent symptoms, and personal disability from recurrent symptoms were collected for each patient. Patients were classified by the cause of recurrent symptoms. Treatment and outcomes were compared using descriptive statistics.
Results: Over a 3-year period, 156 patients were evaluated and diagnosed with TOS. Twenty-two patients presented for recurrent symptoms after anterior scalenectomy and first rib resection. Sixteen were treated for neurogenic TOS (nTOS), one for arterial TOS, and five for venous TOS (vTOS). In patients with nTOS, the cause of recurrent symptoms was repeat injury (n ¼ 5), dense scar tissue (n ¼ 10), or residual cervical rib (n ¼ 1). Four patients with vTOS presented with new-onset symptoms including numbness and tingling down the arm into the hand. Three of these were due to residual posterior rib segments, and one was due to extensive scar tissue with calcification along the supraclavicular and infraclavicular incisions. The final patient presented with pain and swelling after subclavian vein stent thrombosis. In both nTOS and vTOS cases where residual rib was present, repeat surgical resection resulted in complete symptom resolution. In the 15 nTOS patients with recurrent symptoms due to scar tissue or recurrent injury, TOS-specific physical therapy was more effective at relieving symptoms than non-TOS specific physical therapy. Adjuncts to physical therapy include botulinum toxin and trigger point injections as well as use of oral muscle relaxants during physical therapy. One patient underwent surgical decompression of the carpal and cubital tunnels with excellent results.
Conclusions: Care must be taken with first rib resection for vTOS cases to ensure complete posterior rib resection to prevent new onset neurogenic symptoms. For patients with recurrent nTOS symptoms, a physical therapy protocol designed for TOS with adjunct pain management improves outcomes over use of nonspecific physical therapy. Objectives: The objective of this study was to investigate the association between depression and mortality in older adults undergoing endovascular or open interventions for peripheral arterial disease (PAD).
Methods: This was a preplanned analysis of the FRaily Assessment In Lower Extremity arterial Disease (FRAILED) prospective cohort study including two centers in Montreal, Canada, designed to examine frailty in patients with PAD. Consecutive patients undergoing endovascular or open interventions for PAD (Rutherford class $3) were enrolled. Depression was assessed before the intervention using the 15-item Geriatric Depression Scale Short Form, with a score >5 being consistent with depression. The primary outcome was all-cause mortality at 6 months. The secondary outcomes were readmission or need for reintervention.
Results: Among 149 older adults with a mean age of 70.3 6 11.1 years, 54.7% received endovascular interventions and 45.3% received open interventions. The prevalence of screened depression was 28.4% (n ¼ 42), whereas this had been documented in only 3.3% (n ¼ 5) of patients in the clinical record. Among those who were depressed, 27.2% received endovascular interventions and 29.9% received open interventions. The incidence of all-cause mortality was 10.0% (n ¼ 15) in the depressed group and 1.3% (n ¼ 2) in the nondepressed group. Univariate analysis demonstrated that depressive symptoms were associated with low appetite, weight loss, and anemia. After adjusting for age, sex, predicted operative risk with the revised cardiac risk index, and procedure type, worsening depression scores were found to be independently predictive of 6-month mortality (odds ratio [OR], 1.48; 95% confidence interval [CI], 1.08-2.29), but not of vascular reintervention (OR, 1.11; 95% CI, 0.99-1.26) or readmission (OR, 1.16; 95% CI, 0.96-1.39).
Conclusions: Depression is underdiagnosed in older adults undergoing endovascular or open interventions for PAD. Worsening depression scores using the Geriatric Depression Scale Short Form were found to be predictive of all-cause mortality 6-months after the intervention. The effect of depression on mortality did not appear to be mediated by a higher risk of reintervention or readmission.
Author Disclosures: M. Ades: Nothing to disclose; J. Afilalo: Nothing to disclose; C. Boudrias: Nothing to disclose; L. M. Drudi: Nothing to disclose; M. Grenon: Nothing to disclose; R. Mancini: Nothing to disclose; O. Steinmetz: Nothing to disclose. Objectives: Patients with neurogenic thoracic outlet syndrome (nTOS) live with daily discomfort that may change activities, strain personal relationships, and limit work ability. Typical treatment pathways for patients with nTOS start with physical therapy to relieve symptoms and possible surgical therapy. This study compared outcomes of early first rib resection and anterior scalenectomy to delayed surgical treatment in patients with severe nTOS.
Methods: All patients presenting for TOS are enrolled in a prospective database. At the time of enrollment and at each follow-up visit, patients complete a brief pain inventory, 12-item Short Form Health Survey, and the 11-item version of the Disabilities of the Arm, Shoulder and Hand (Quick-DASH) survey. Patients who underwent early surgery, after the initial consultation, were compared to those that underwent delayed surgical treatment, after an initial round of TOS specific physical therapy. Patient demographics, personal disability from symptoms, and outcomes after surgery were recorded and compared using c 2 analysis for categoric variables and t-test for continuous variables.
Results: Over a 3-year period, 156 patients were evaluated for TOS, and 118 of these patients were evaluated for nTOS. Sufficient data for analysis was recorded for 31 nTOS patients; of these, 12 patients received early surgery, and 19 patients underwent TOS-specific physical therapy, followed by surgery. All patients were new to the TOS clinic. Patients in the early group were younger (35 years vs 46 years; P ¼ .23). Seven patients in the early group had symptoms for >1 year, and 16 patients in the late group (58% vs 84%; P ¼ .12) had prolonged symptoms. There were no differences in the mean pain scores (5.6 vs 4.3; P ¼ .29) or work ability (6.4 vs 4.6; P ¼ .29); however, patients in the early group tended to have symptoms that interfered more with joy of life (6.2 vs 3.5; P ¼ .08). Two patients in the late group had complete resolution of symptoms; however, most patients had only partial resolution of symptoms (early ¼ 10, late ¼ 9; P ¼ .15). There was also no difference in the number of patients that returned to work in the early vs late group (5 vs 8; P ¼ .39).
Conclusions: For patients with severe prolonged symptoms due to nTOS, early surgery has similar results to delaying surgery for preoperative physical therapy. In this difficult treatment group, understanding personal limitations using objective survey measures aids in postoperative expectation counseling, but preoperative physical therapy may not offer additional benefit. Objectives: Patients with peripheral arterial disease (PAD) have a high incidence of cardiovascular disease and current guidelines recommend treatment with antiplatelet agents (AP), 3-hydroxy-3 methyl-glutaryl-coenzyme A reductase inhibitors (statins) and angiotensin converting enzyme inhibitors or angiotensin receptor blocker (ACEi/ARB). The purpose of this study was to evaluate the trend in the use of these medications in a large diverse patient population managed at routine clinical practice.
Methods: We identified privately insured and Medicare Advantage enrollees with a diagnosis of intermittent claudication (IC) or critical limb ischemia (CLI) by International Classification of Diseases-9/10 codes within the OptumLabs administrative claims database between 2006
